ICON PLC (ICLR)
IE0005711209 - Common Stock
Overall ICLR gets a fundamental rating of 5 out of 10. We evaluated ICLR against 58 industry peers in the Life Sciences Tools & Services industry. ICLR has an average financial health and profitability rating. ICLR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
In the past year ICLR had a positive cash flow from operations.
In the past 5 years ICLR has always been profitable.
In the past 5 years ICLR always reported a positive cash flow from operatings.
1.2 Ratios
ICLR's Return On Assets of 4.01% is fine compared to the rest of the industry. ICLR outperforms 75.86% of its industry peers.
ICLR has a better Return On Equity (7.24%) than 77.59% of its industry peers.
With a decent Return On Invested Capital value of 6.16%, ICLR is doing good in the industry, outperforming 75.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICLR is significantly below the industry average of 10.75%.
The last Return On Invested Capital (6.16%) for ICLR is above the 3 year average (4.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.01% | ||
| ROE | 7.24% | ||
| ROIC | 6.16% |
ROA(3y)2.48%
ROA(5y)5.99%
ROE(3y)4.82%
ROE(5y)11.11%
ROIC(3y)4.59%
ROIC(5y)9.41%
1.3 Margins
Looking at the Profit Margin, with a value of 8.30%, ICLR is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
ICLR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 13.37%, ICLR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
ICLR's Operating Margin has declined in the last couple of years.
ICLR has a Gross Margin of 29.67%. This is in the lower half of the industry: ICLR underperforms 74.14% of its industry peers.
In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.37% | ||
| PM (TTM) | 8.3% | ||
| GM | 29.67% |
OM growth 3Y-4.19%
OM growth 5Y-2.83%
PM growth 3Y-14.06%
PM growth 5Y-9.51%
GM growth 3Y0.39%
GM growth 5Y-0.2%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
The number of shares outstanding for ICLR has been increased compared to 1 year ago.
Compared to 5 years ago, ICLR has more shares outstanding
ICLR has a better debt/assets ratio than last year.
2.2 Solvency
ICLR has an Altman-Z score of 3.00. This indicates that ICLR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ICLR (3.00) is comparable to the rest of the industry.
The Debt to FCF ratio of ICLR is 2.99, which is a good value as it means it would take ICLR, 2.99 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.99, ICLR belongs to the best of the industry, outperforming 84.48% of the companies in the same industry.
ICLR has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
ICLR has a Debt to Equity ratio of 0.36. This is comparable to the rest of the industry: ICLR outperforms 41.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.99 | ||
| Altman-Z | 3 |
ROIC/WACC0.68
WACC9.07%
2.3 Liquidity
A Current Ratio of 1.21 indicates that ICLR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.21, ICLR is doing worse than 91.38% of the companies in the same industry.
A Quick Ratio of 1.21 indicates that ICLR should not have too much problems paying its short term obligations.
ICLR's Quick ratio of 1.21 is on the low side compared to the rest of the industry. ICLR is outperformed by 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.20% over the past year.
The Earnings Per Share has been growing by 15.96% on average over the past years. This is quite good.
ICLR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.29%.
Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 25.62% on average per year.
EPS 1Y (TTM)12.2%
EPS 3Y25.12%
EPS 5Y15.96%
EPS growth Q2Q19.66%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y42.65%
Revenue growth 5Y25.62%
Revenue growth Q2Q5.65%
3.2 Future
ICLR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 6.88% on average per year.
EPS Next Y19.37%
EPS Next 2Y16.7%
EPS Next 3Y15.13%
EPS Next 5Y11.26%
Revenue Next Year6.02%
Revenue Next 2Y6.66%
Revenue Next 3Y6.81%
Revenue Next 5Y6.88%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 23.59 indicates a rather expensive valuation of ICLR.
ICLR's Price/Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 93.10% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.60. ICLR is around the same levels.
ICLR is valuated rather expensively with a Price/Forward Earnings ratio of 18.10.
ICLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 94.83% of the companies in the same industry.
ICLR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.59 | ||
| Fwd PE | 18.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 91.38% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 93.10% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.21 | ||
| EV/EBITDA | 17.23 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ICLR may justify a higher PE ratio.
ICLR's earnings are expected to grow with 15.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.22
PEG (5Y)1.48
EPS Next 2Y16.7%
EPS Next 3Y15.13%
5. Dividend
5.1 Amount
ICLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ICON PLC
NASDAQ:ICLR (5/17/2024, 7:05:20 PM)
After market: 314.72 0 (0%)314.72
-1.11 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.02B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.59 | ||
| Fwd PE | 18.1 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.22
PEG (5Y)1.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.01% | ||
| ROE | 7.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.37% | ||
| PM (TTM) | 8.3% | ||
| GM | 29.67% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.21 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)12.2%
EPS 3Y25.12%
EPS 5Y
EPS growth Q2Q
EPS Next Y19.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.29%
Revenue growth 3Y42.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y